- Report
- January 2026
- 385 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 376 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 278 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 276 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 180 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 254 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 376 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 225 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 174 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 279 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 174 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 280 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 349 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 130 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 382 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 282 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 276 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 254 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 282 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 149 Pages
Global
From €5206EUR$5,850USD£4,520GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more